Thinking about buying stock in Adagio Therapeutics, 180 Life Sciences, InMed Pharmaceuticals, Beyondspring, or Inovio Pharmaceuticals?
NEW YORK, Nov. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ADGI, ATNF, INM, BYSI, and INO.
To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.
- ADGI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ADGI&prnumber=112920211
- ATNF: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATNF&prnumber=112920211
- INM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=INM&prnumber=112920211
- BYSI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=BYSI&prnumber=112920211
- INO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=INO&prnumber=112920211
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-adagio-therapeutics-180-life-sciences-inmed-pharmaceuticals-beyondspring-or-inovio-pharmaceuticals-301432846.html
180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful Dupuytren’s Phase 2b Clinical Trial Results
Yahoo 12/06 08:15 ET
U.S. prepares to fast-track authorization of Omicron COVID vaccines
SA Breaking News 12/06 05:59 ET
Adagio, Vir among weekly healthcare gainers; Novavax slips ahead of more data on Omicron
SA Breaking News 12/04 21:00 ET
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
Yahoo 12/04 07:52 ET
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
Yahoo 12/03 16:15 ET
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail?
Yahoo 12/03 12:34 ET
2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
Yahoo 12/03 10:30 ET
BeyondSpring: Not Beyond Hope Yet, Says Analyst
Yahoo 12/03 03:04 ET
SHAREHOLDER ALERT: Investigation of BeyondSpring, Inc. Announced by Holzer & Holzer, LLC
Yahoo 12/02 14:47 ET
--Evercore ISI Adjusts BeyondSpring PT to $25 From $95, Maintains Outperform Rating
MT Newswires 12/02 13:06 ET